Safety and efficacy of the endothelin receptor antagonist macitentan in pediatric pulmonary hypertension.
Schweintzger S, Koestenberger M, Schlagenhauf A, Grangl G, Burmas A, Kurath-Koller S, Pocivalnik M, Sallmon H, Baumgartner D, Hansmann G, Gamillscheg A.
Schweintzger S, et al. Among authors: grangl g.
Cardiovasc Diagn Ther. 2020 Oct;10(5):1675-1685. doi: 10.21037/cdt.2020.04.01.
Cardiovasc Diagn Ther. 2020.
PMID: 33224780
Free PMC article.